UroPharma
PrivateLast Round
Early Funding
May 21, 2018
Total Funding Raised
$2.04M
Company Overview
UroPharma is a MedTech company that develops precision drug-device platforms for direct-to-bladder therapies to treat urological and urogynecological diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UroPharma Comparables
Compare UroPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Physion S.r.l. | 88% | |
| Combat Medical | 82% | |
| Vensica Medical | 80% | |
UroPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 21, 2018 | ||||
| Seed | May 21, 2018 |
Key People
Founding team and executive leadership
UroPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 8, 2024
Grew 50% QoQ from 6 to 9 employees.
- May 21, 2018
Raised $25M in early funding.
UroPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about UroPharma's valuation, stock price, and market status.